Long Noncoding RNA <i>ANRIL</i> as a Novel Biomarker in Human Cancer
Ning Lou, Guohong Liu, Yunbao Pan
Abstract
The long noncoding RNA ANRIL, located in the human chromosome 9p21 region, has been reported to be involved in tumor progression. ANRIL regulates gene expression via recruiting PRC2 or titrating miRNA; it also participates in signaling pathways. Evidence has indicated that ANRIL is overexpressed in many cancer types and is capable of enhancing cell proliferation and cell cycle progression and inhibiting apoptosis and senescence. ANRIL has the potential to serve as a biomarker for diagnosis and prognosis in cancer. In this article we focus on recent advances in studies of the oncogenic role of ANRIL and its potential role in cancer medicine.
Topics & Concepts
Long non-coding RNAPRC2BiomarkermicroRNACancer researchCancerNon-coding RNARNABiologyGene expressionMedicineGeneComputational biologyEZH2GeneticsCancer-related molecular mechanisms researchRNA modifications and cancerCircular RNAs in diseases